Dr. Lieping Chen earned his medical degree from Fujian Medical School in China. After clinical training in immunology and oncology in Fujian Union Hospital and Peking Union Medical College, he earned a PhD in Pathology in Drexel University in Philadelphia and did a postdoctoral fellowship in the University of Washington in Seattle. He worked as a research scientist in Bristol-Myers Squibb from 1989-1997 before he joined Mayo Clinic as Immunology Professor from 1997-2004. He was Professor of Oncology and Dermatology in Johns Hopkins University School of Medicine for 7 years and he joined Yale University in 2011.
Dr. Chen has published more than 300 research articles and edited two books. His work in discovery of the PD-1/PD-L1 pathway in cancer therapy was cited as the #1 breakthrough of the years by Science magazine (2013). He has received several awards and professional recognitions including Inaugural United Technologies Endowed Chair of Yale University (2013) and William B. Coley Award (2014).